Cartesian Therapeutics
RNAC
#6768
Rank
ยฃ0.38 B
Marketcap
ยฃ15.04
Share price
13.33%
Change (1 day)
-45.80%
Change (1 year)

EPS for Cartesian Therapeutics (RNAC)

EPS in 2023 (TTM): -ยฃ0.26

According to Cartesian Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.26. In 2021 the company made an earnings per share (EPS) of -ยฃ0.19 an increase over its 2020 EPS that were of -ยฃ0.55.

EPS history for Cartesian Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.26
2021-ยฃ0.19-65.22%
2020-ยฃ0.55-43.44%
2019-ยฃ0.97-58.08%
2018-ยฃ2.32-9.35%
2017-ยฃ2.56-29.16%
2016-ยฃ3.62